You searched for metabolic diseases - Page 26 of 62

News and Trends 24 May 2018

Organs-on-a-Chip for Drug Research in a Range of Diseases Make it to the Market

…and Asia, could benefit research into treatments for diseases such as cancer and Alzheimer’s. PhysioMimix, an organ-on-a-chip device, has open-well plates in which cells or pre-formed tissues can be placed…

May 24, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 17 May 2023

Diagnosing inflammatory diseases with synthetic peptides

…translate the assay into a product that can bring the diagnostic power of this increasingly important biomarker to a new level to help patients suffering from inflammatory diseases,” Heinis said….

May 17, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 2 Oct 2024

Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder

…resources and a team of disease specialists. The push to develop drugs for rare diseases Janet Maynard, director of CDER’s Office of Rare Diseases, Pediatrics, Urologic, and Reproductive Medicine, said…

October 2, 2024 - 7 minutesmins - By Willow Shah-Neville

News and Trends 25 May 2023

PharmEnable raises $7.5M to develop small molecule drugs to treat cancer and neurological diseases

…to improved selectivity and ultimately reduce attrition rates. The aim is to develop therapies that are highly effective with fewer side effects to treat diseases with a high clinical need….

May 25, 2023 - 2 minutesmins - By Jim Cornall

glucagon zealand pharma diabetes insulin immunotherapy

News and Trends 20 May 2022

Zealand Pharma’s drug for rare metabolic disease smashes phase III

…been diazoxide, which can’t benefit all patients and can cause side effects including nausea and high blood sugar. “As with many other rare diseases, CHI only recently started to get…

May 20, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 10 Nov 2022

SOTIO reveal potential treatment for adults with solid tumors at SITC meeting

…cell, BOXR1030, as a potential clinical treatment for the 90% of adult cancer patients with solid tumors. SOTIO: strong clinical path “The GOT2 infused CAR-T cell therapy improved metabolic fitness,…

November 10, 2022 - 4 minutesmins - By Liza Laws

News and Trends 21 Dec 2018

French Scientists Find a Weak Spot in HIV-Infected Cells

…the French scientists unveiled that HIV prefers to infect those T cells with higher metabolic activity, making them a promising target to get rid of the latent virus. T cells…

December 21, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 14 May 2018

Could Stem Cells Replace Animal Testing in Drug Development?

…an answer to this dilemma as well. There are already iPS cell models available for multiple genetic diseases, including neurological disorders like Parkinson’s as well as blood diseases, cardiac syndromes,…

May 14, 2018 - 6 minutesmins - By Timothé Cynober

News and Trends 31 Jan 2017

New British Biotech-Academia Alliance takes on Cardiovascular Disease

Heptares Therapeutics and the University of Cambridge have partnered to investigate a novel target for cardiovascular diseases. Heptares Therapeutics, based in London, develops drugs against historically undruggable G protein-coupled receptors…

January 31, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

alchemyrefiner alchemymagic 3 04e4a427 d1fa 4258 9dab 2690330368fd 0

Podcast 19 Apr 2024

The biotech investment landscape in 2024

…disease areas and look across therapeutic areas. So these days we’re very excited about metabolic and obesity and some of the adjacencies like liver diseases,” she explained. Data and disruption:…

April 19, 2024 - 8 minutesmins - By Jim Cornall

In Depth 11 Dec 2024

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

…also contribute to immune dysfunction in inflammatory and autoimmune diseases, and targeting sialoglycans and/or their receptors could have therapeutic potential in suppressing the immune system in these diseases. In addition,…

December 11, 2024 - 9 minutesmins - By Willow Shah-Neville

News and Trends 11 Jan 2018

German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study

…II trials for both ulcerative colitis and Crohn’s disease (CD). Dihydroorotatede hydrogenase (DHODH) inhibition causes metabolic stress in active immune cells, leading to their altered function or apoptosis. With diseases…

January 11, 2018 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Organs-on-a-Chip for Drug Research in a Range of Diseases Make it to the Market

Diagnosing inflammatory diseases with synthetic peptides

Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder

PharmEnable raises $7.5M to develop small molecule drugs to treat cancer and neurological diseases

Zealand Pharma’s drug for rare metabolic disease smashes phase III

SOTIO reveal potential treatment for adults with solid tumors at SITC meeting

French Scientists Find a Weak Spot in HIV-Infected Cells

Could Stem Cells Replace Animal Testing in Drug Development?

New British Biotech-Academia Alliance takes on Cardiovascular Disease

The biotech investment landscape in 2024

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!